Announcements Trials

Browse Landscape

Phase

Status

Completed 51 Active not recruiting 15 Recruiting 11 Terminated 9 Unknown 5 Withdrawn 1 Not yet recruiting 1

Sponsor Class

OTHER 91 INDUSTRY 33 NIH 3 OTHER_GOV 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 4 Non-Muscle Invasive Bladder Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Sarcoma, Kaposi 2 Sarcoma, Alveolar Soft Part 2 Prostatic Neoplasms 2 Melanoma 2 Lymphoma 2 Colorectal Neoplasms 2 Clear-cell metastatic renal cell carcinoma 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Urinary Incontinence 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Solid Tumor 1 Skin Neoplasms 1 Sarcoma, Synovial 1 Sarcoma, Clear Cell 1 Sarcoma 1 Rhabdomyosarcoma 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Neurofibrosarcoma 1 Neoplasms 1 Musculoskeletal Pain 1 Multiple Myeloma 1 Malignant Solid Neoplasm 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × NETWORK × Multiple Myeloma × Clear all

NCT05944783 2025-02-12

BE-Dasatinib

Centro de Atencion e Investigacion Medica

Phase 4 Not yet recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡